Exelixis Statistics
Total Valuation
Exelixis has a market cap or net worth of $6.58 billion. The enterprise value is $5.82 billion.
Market Cap | 6.58B |
Enterprise Value | 5.82B |
Important Dates
The next estimated earnings date is Tuesday, July 30, 2024, after market close.
Earnings Date | Jul 30, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Exelixis has 291.29 million shares outstanding. The number of shares has decreased by -6.36% in one year.
Shares Outstanding | 291.29M |
Shares Change (YoY) | -6.36% |
Shares Change (QoQ) | -2.39% |
Owned by Insiders (%) | 2.20% |
Owned by Institutions (%) | 88.77% |
Float | 255.18M |
Valuation Ratios
The trailing PE ratio is 35.31 and the forward PE ratio is 16.21. Exelixis's PEG ratio is 1.69.
PE Ratio | 35.31 |
Forward PE | 16.21 |
PS Ratio | 3.56 |
Forward PS | 3.41 |
PB Ratio | 3.09 |
P/FCF Ratio | 23.54 |
PEG Ratio | 1.69 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.61, with an EV/FCF ratio of 20.82.
EV / Earnings | 28.39 |
EV / Sales | 3.15 |
EV / EBITDA | 18.61 |
EV / EBIT | 22.52 |
EV / FCF | 20.82 |
Financial Position
The company has a current ratio of 3.47, with a Debt / Equity ratio of 0.09.
Current Ratio | 3.47 |
Quick Ratio | 3.23 |
Debt / Equity | 0.09 |
Debt / EBITDA | 0.64 |
Debt / FCF | 0.72 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.90% and return on invested capital (ROIC) is 5.84%.
Return on Equity (ROE) | 8.90% |
Return on Assets (ROA) | 6.90% |
Return on Capital (ROIC) | 5.84% |
Revenue Per Employee | $1.41M |
Profits Per Employee | $156,530 |
Employee Count | 1,310 |
Asset Turnover | 0.62 |
Inventory Turnover | 3.12 |
Taxes
In the past 12 months, Exelixis has paid $53.46 million in taxes.
Income Tax | 53.46M |
Effective Tax Rate | 20.68% |
Stock Price Statistics
The stock price has increased by +15.66% in the last 52 weeks. The beta is 0.54, so Exelixis's price volatility has been lower than the market average.
Beta (5Y) | 0.54 |
52-Week Price Change | +15.66% |
50-Day Moving Average | 21.78 |
200-Day Moving Average | 22.07 |
Relative Strength Index (RSI) | 58.33 |
Average Volume (20 Days) | 1,581,272 |
Short Selling Information
The latest short interest is 9.19 million, so 3.15% of the outstanding shares have been sold short.
Short Interest | 9.19M |
Short Previous Month | 9.94M |
Short % of Shares Out | 3.15% |
Short % of Float | 3.60% |
Short Ratio (days to cover) | 5.07 |
Income Statement
In the last 12 months, Exelixis had revenue of $1.85 billion and earned $205.05 million in profits. Earnings per share was $0.64.
Revenue | 1.85B |
Gross Profit | 1.77B |
Operating Income | 171.52M |
Pretax Income | 258.51M |
Net Income | 205.05M |
EBITDA | 312.76M |
EBIT | 258.51M |
Earnings Per Share (EPS) | $0.64 |
Balance Sheet
The company has $963.26 million in cash and $201.47 million in debt, giving a net cash position of $761.79 million or $2.62 per share.
Cash & Cash Equivalents | 963.26M |
Total Debt | 201.47M |
Net Cash | 761.79M |
Net Cash Per Share | $2.62 |
Equity (Book Value) | 2.13B |
Book Value Per Share | 7.31 |
Working Capital | 919.42M |
Cash Flow
In the last 12 months, operating cash flow was $317.74 million and capital expenditures -$38.14 million, giving a free cash flow of $279.60 million.
Operating Cash Flow | 317.74M |
Capital Expenditures | -38.14M |
Free Cash Flow | 279.60M |
FCF Per Share | $0.93 |
Margins
Gross margin is 95.70%, with operating and profit margins of 9.29% and 11.10%.
Gross Margin | 95.70% |
Operating Margin | 9.29% |
Pretax Margin | 14.00% |
Profit Margin | 11.10% |
EBITDA Margin | 16.94% |
EBIT Margin | 14.00% |
FCF Margin | 15.14% |
Dividends & Yields
Exelixis does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 6.36% |
Shareholder Yield | 6.36% |
Earnings Yield | 3.11% |
FCF Yield | 4.25% |
Analyst Forecast
The average price target for Exelixis is $26.64, which is 17.88% higher than the current price. The consensus rating is "Buy".
Price Target | $26.64 |
Price Target Difference | 17.88% |
Analyst Consensus | Buy |
Analyst Count | 14 |
Revenue Growth Forecast (5Y) | 8.33% |
EPS Growth Forecast (5Y) | 35.03% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Exelixis has an Altman Z-Score of 7.07 and a Piotroski F-Score of 6.
Altman Z-Score | 7.07 |
Piotroski F-Score | 6 |